🇺🇸 FDA
Pipeline program

Peramivir

BCX1812-305

Phase 3 small_molecule completed

Quick answer

Peramivir for Influenza is a Phase 3 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 5 ClinicalTrials.gov record(s).

Program details

Company
BIOCRYST PHARMACEUTICALS INC
Indication
Influenza
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials